Skip to main content
. 2014 Oct 8;13:157. doi: 10.1186/1476-511X-13-157

Table 5.

Distribution of genotype and allele frequencies of the APOB polymorphisms with the major variables analyzed among the Kuwaiti population (n = 795)

TC TG HDL-C LDL-C FH-HC FH-HTG
Normal (≤5.17) High (>5.17) Normal (≤1.70) High (>1.70) Normal (>1.1 men & >1.29 women) Abnormal (≤1.1 men & ≤1.29 women) Normal (≤3.2) High (>3.2) Absent Present Absent Present
n 475 191 571 95 211 418 389 238 409 197 594 12
APOB signal peptide (rs11279109)
II n (%) 277 (58.3) 118 (61.8) 338 (57.4) 67 (70.5) 118 (55.9) 258 (61.7) 233 (59.9) 141 (59.2) 248 (60.64) 121 (61.42) 364 (61.28) 5 (41.67)
ID n (%) 172 (36.2) 59 (30.9) 210 (36.8) 21 (22.1) 81 (38.4) 135 (32.3) 134 (34.5) 82 (34.5) 138 (33.7) 63 (32.0) 198 (33.3) 3 (25.0)
DD n (%) 26 (5.5) 14 (7.3) 33 (5.8) 7 (7.4) 12 (5.7) 25 (6.0) 22 (5.7) 15 (6.3) 23 (5.6) 13 (6.6) 32 (5.4) 4 (33.3)
p 0.338 0.021 0.313 0.944 0.839 0.004
D (f) 0.236 0.228 0.242 0.184 0.249 0.221 0.229 0.235 0.225 0.226 0.221 0.458
I (f) 0.764 0.772 0.758 0.816 0.751 0.779 0.771 0.765 0.775 0.774 0.779 0.542
p 0.754 0.083 0.274 0.791 0.970 0.006
APOB Codon 2488C (rs693)
X X n (%) 239 (50.3) 104 (54.5) 292 (51.1) 51 (53.7) 111 (52.6) 217 (52.6) 206 (53.0) 122 (51.3) 226 (55.3) 106 (53.8) 326 (54.9) 6 (50.0)
X + X- n (%) 199 (41.9) 73 (38.2) 234 (41.0) 38 (40.0) 84 (39.8) 168 (40.2) 152 (39.1) 98 (41.2) 153 (37.4) 79 (40.1) 229 (38.6) 3 (25.0)
X + X + n (%) 37 (7.8) 14 (7.3) 45 (7.9) 6 (6.3) 16 (7.6) 33 (7.9) 31 (8.0) 18 (7.6) 30 (7.3) 12 (6.1) 39 (6.6) 3 (25.0)
p 0.625 0.826 0.982 0.871 0.741 0.041
X (f) 0.713 0.736 0.716 0.737 0.725 0.720 0.725 0.718 0.740 0.739 0.742 0.625
X + (f) 0.287 0.264 0.284 0.263 0.275 0.280 0.275 0.282 0.260 0.261 0.258 0.375
p 0.399 0.559 0.851 0.805 0.969 0.198
APOB Codon 3611–MspI G (rs1801701)
M + M + n (%) 407(85.7) 172(90.1) 494(86.5) 85(89.5) 180(85.3) 368(88.0) 337(86.6) 209(87.8) 362(88.5) 162(82.2) 516(86.9) 8(66.7)
M + M n (%) 65(13.7) 18(9.4) 75(13.1) 8(8.4) 30(14.2) 47(11.2) 49(12.6) 28(11.8) 45(11.0) 35(17.8) 76(12.8) 4(33.3)
M M n (%) 3(0.6) 1(0.5) 2(0.4) 2(2.1) 1(0.5) 3(0.7) 3(0.8) 1(0.4) 2(0.5) 0(0.0) 2(0.3) 0(0.0)
p 0.315 0.058 0.532 0.822 0.046 0.113
M (f) 0.075 0.052 0.069 0.063 0.076 0.063 0.071 0.063 0.060 0.089 0.067 0.167
M + (f) 0.925 0.948 0.931 0.937 0.924 0.937 0.929 0.937 0.940 0.911 0.933 0.833
p 0.143 0.761 0.407 0.600 0.063 0.079
APOB Codon 4154G (rs1042031)
E + E + n (%) 383(80.6) 154(80.6) 461(80.7) 76(80.0) 174(82.5) 334(79.9) 319(82.0) 187(78.6) 321(78.5) 158(80.2) 468(78.8) 11(91.7)
E + E n (%) 83(17.5) 35(18.3) 102(17.9) 16(16.8) 34(16.1) 77(18.4) 63(16.2) 48(20.2) 82(20.0) 33(16.8) 114(19.2) 1(8.3)
E E n (%) 8(1.9) 2(1.1) 8(1.4) 3(3.2) 3(1.4) 7(1.7) 7(1.8) 3(1.3) 6(1.5) 6(3.0) 12(2.0) 0(0.0)
p 0.723 0.455 0.743 0.406 0.289 0.543
E (f) 0.106 0.102 0.103 0.116 0.095 0.109 0.099 0.113 0.115 0.114 0.116 0.042
E + (f) 0.894 0.898 0.897 0.884 0.905 0.891 0.901 0.887 0.885 0.886 0.884 0.958
p 0.820 0.604 0.441 0.416 0.971 0.257
APOB 3 VNTR
MM n (%) 391(82.3) 157(82.2) 466(81.6) 82(86.3) 174(82.5) 345(82.5) 321(82.5) 197(82.8) 339(82.9) 168(85.3) 496(83.5) 11(91.7)
ML n (%) 68(14.3) 30(15.7) 88(15.4) 10(10.5) 30(14.2) 62(14.8) 56(14.4) 35(14.7) 56(13.7) 22(11.2) 77(13.0) 1(8.3)
LL n (%) 16(3.4) 4(2.1) 17(3.0) 3(3.2) 7(3.3) 11(2.6) 12(3.1) 6(2.5) 14(3.4) 7(3.6 21(3.5) 0(0.0)
p 0.633 0.461 0.875 0.916 0.685 0.700
L (f) 0.105 0.099 0.107 0.084 0.104 0.100 0.103 0.099 0.103 0.091 0.100 0.042
M (f) 0.895 0.901 0.893 0.916 0.896 0.900 0.897 0.901 0.897 0.909 0.900 0.958
p 0.754 0.343 0.834 0.816 0.537 0.503

TC total cholesterol (expressed in mmol/L); TG triglycerides (expressed in mmol/L); LDL-C low density lipoprotein-cholesterol; HDL-C high density lipoprotein-cholesterol; FH-HTG positive family history of hypertriglyceridemia, FH-HC positive family history of hypercholesterolemia.

n = number of samples,% = frequency for each genotype in percent and ratio (f) for the allele.

The p-values were determined by chi-square test at a significance level of p = 0.05.